Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dual adaptor of phosphotyrosine and 3-phosphoinositides 1 (DAPP1), also known as BAM32, is an adaptor protein expressed predominantly in B lymphocytes and other immune cells[1][2][4][6]. It contains an N-terminal Src homology 2 (SH2) domain and a C-terminal pleckstrin homology (PH) domain[4][5]. DAPP1 is rapidly recruited to the plasma membrane upon B cell receptor (BCR) engagement, where it is phosphorylated by Src-family kinases (such as Lyn) in a phosphatidylinositol 3-kinase (PI3K)-dependent manner[1][2][5]. DAPP1 serves as a scaffold that coordinates signaling complexes by binding 3-phosphoinositide lipids and interacting with proteins like phospholipase C gamma 2 (PLCγ2), promoting activation of pathways involved in cytoskeletal remodeling, receptor internalization, cell adhesion, and spreading[1][2][3][5][7]. It plays a critical role in BCR-mediated antigen presentation, efficient formation of immune synapses, and the generation of high-affinity antibody responses[1][3][7]. DAPP1 is also involved in regulating responses in neutrophils and dendritic cells and is required for reactive oxygen species production during inflammation[9]. There are no drugs or small molecules currently known to target DAPP1 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dual adaptor of phosphotyrosine and 3-phosphoinositides 1 (DAPP1).